我赞成
发表于 2025-3-21 16:36:13
书目名称Chemotherapy and Radiotherapy of Gastrointestinal Tumors影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0224968<br><br> <br><br>书目名称Chemotherapy and Radiotherapy of Gastrointestinal Tumors影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0224968<br><br> <br><br>书目名称Chemotherapy and Radiotherapy of Gastrointestinal Tumors网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0224968<br><br> <br><br>书目名称Chemotherapy and Radiotherapy of Gastrointestinal Tumors网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0224968<br><br> <br><br>书目名称Chemotherapy and Radiotherapy of Gastrointestinal Tumors被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0224968<br><br> <br><br>书目名称Chemotherapy and Radiotherapy of Gastrointestinal Tumors被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0224968<br><br> <br><br>书目名称Chemotherapy and Radiotherapy of Gastrointestinal Tumors年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0224968<br><br> <br><br>书目名称Chemotherapy and Radiotherapy of Gastrointestinal Tumors年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0224968<br><br> <br><br>书目名称Chemotherapy and Radiotherapy of Gastrointestinal Tumors读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0224968<br><br> <br><br>书目名称Chemotherapy and Radiotherapy of Gastrointestinal Tumors读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0224968<br><br> <br><br>
CRUMB
发表于 2025-3-21 20:49:36
https://doi.org/10.1007/978-3-642-19146-61973. There are now 39 institutions in the Netherlands, Germany, Switzerland, Italy, Spain, France, Israel, and Belgium contributing to the various clinical trials. They have already registered 1,350 patients, of whom 950 are evaluable for the studies. Seven clinical trials are still in progress or
宽敞
发表于 2025-3-22 03:11:36
http://reply.papertrans.cn/23/2250/224968/224968_3.png
重画只能放弃
发表于 2025-3-22 05:54:13
https://doi.org/10.1007/978-3-642-19199-2” surgery alone often proves inadequate, many types of postoperative adjuvant procedures have been applied in an attempt to improve the long-term survival rates. Systemic adjuvant therapy generally consists of either chemotherapy or immunotherapy, and after radical surgery, the 5-year survival rates
符合你规定
发表于 2025-3-22 12:08:32
On a Change of SU(3) into Three SU(2),U(1)azoxane. Thirty-one patients were Duke’s group A; 49 group B; 61 group C; and 17 group D; an additional four patients were randomized in error..The adjuvant group received the usual clinical care and 125 mg razoxane twice daily for 5 consecutive days (Monday–friday) every week indefinitely. Control
Obituary
发表于 2025-3-22 13:39:41
https://doi.org/10.1007/978-3-642-19199-2new cases of malignant RS tumors were diagnosed; of these, 1,103 were in males, representing 6% of all male malignant tumors (incidence per 100,000 = 22.6). In females, 864 new cases were diagnosed, representing 5.1% of all female tumors (incidence per 100,000 = 16.3).
Obituary
发表于 2025-3-22 19:43:10
On a Change of SU(3) into Three SU(2),U(1)orouracil (5-FU) . Furthermore, the reported long serum half-life of ftorafur of approximately 10–16 h for the beta-phase makes the drug interesting for split-dose schedules. In comparison with single daily injections, split-dose administration of a drug with a long serum
CRAFT
发表于 2025-3-23 00:01:52
http://reply.papertrans.cn/23/2250/224968/224968_8.png
Carminative
发表于 2025-3-23 01:38:36
http://reply.papertrans.cn/23/2250/224968/224968_9.png
发酵剂
发表于 2025-3-23 09:03:04
Geometrical Properties of the U(1) Gaugeexpected. For this reason a comparative pharmacokinetic study of intravenous versus oral application was performed on six patients, as well as a pilot study on 13 patients with adenocarcinomas of different origins. The results show that 5-FU is absorbed rapidly. The biological availability increases